Predictions
Beyond Meat Inc
Start price
Target price
Perf. (%)
€117.58
19.12.20
19.12.20
€120.00
-1.34%
21.12.20
21.12.20
Revenue growth >5% per year expected
D.R. Horton Inc.
Start price
Target price
Perf. (%)
€60.50
18.12.20
18.12.20
-
18.12.21
18.12.21
33.39%
18.04.21
18.04.21
Revenue growth >5% per year expected
Very positive Cash Flow expected
Top 10 in its market
Could be worthwhile Investment >10% per year
Solarwinds Corp.
Start price
Target price
Perf. (%)
€26.20
18.12.20
18.12.20
€20.00
-5.34%
11.01.21
11.01.21
Risky Investment
Deficits in Management
Very bad culture
High risks for its business
Delivery Hero SE
Start price
Target price
Perf. (%)
€119.40
18.12.20
18.12.20
€50.00
18.12.22
18.12.22
-66.20%
18.12.22
18.12.22
Market Leader or Top 3
Sustainability is little important
Little innovation
Very high cyclical dependencies
Gazprom ADR
Start price
Target price
Perf. (%)
€4.69
18.12.20
18.12.20
€6.00
18.12.21
18.12.21
36.89%
28.06.21
28.06.21
Market Leader or Top 3
Fair valuation
Very high dividend yield expected
Strong uniques
Lockheed Martin Corp.
Start price
Target price
Perf. (%)
€286.90
18.12.20
18.12.20
€370.00
18.06.21
18.06.21
11.71%
18.06.21
18.06.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Strong uniques
BHP Group plc
Start price
Target price
Perf. (%)
€21.63
18.12.20
18.12.20
€26.00
18.12.21
18.12.21
17.66%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Undervalued
Higher EBIT margin than peer group
Nagacorp. Ltd
Start price
Target price
Perf. (%)
€1.03
18.12.20
18.12.20
€2.00
18.12.21
18.12.21
-35.10%
19.12.21
19.12.21
Could be very worthwhile Investment >20% year
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€2.74
18.12.20
18.12.20
-
18.12.21
18.12.21
-45.99%
19.12.21
19.12.21
Probably not worthwhile Investment
Sektkellerei Schloss Wachenheim AG
Start price
Target price
Perf. (%)
€15.10
18.12.20
18.12.20
€17.00
0.00%
22.02.21
22.02.21
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.14
18.12.20
18.12.20
€4.00
-2.90%
18.12.20
18.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Adyen NV ADR
Start price
Target price
Perf. (%)
€39.60
18.12.20
18.12.20
€40.00
11.62%
11.02.21
11.02.21
Revenue growth >5% per year expected
Valuable balance sheet
Capable Management
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.12
18.12.20
18.12.20
€3.00
0.49%
18.12.20
18.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.01
18.12.20
18.12.20
€45.00
-1.78%
23.12.20
23.12.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€48.17
18.12.20
18.12.20
€27.00
18.06.21
18.06.21
14.83%
19.01.21
19.01.21
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.01
18.12.20
18.12.20
€34.00
18.12.21
18.12.21
-5.35%
15.03.21
15.03.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Rheinmetall AG
Start price
Target price
Perf. (%)
€86.54
18.12.20
18.12.20
€96.00
21.04.21
21.04.21
-0.60%
16.03.21
16.03.21
Top 10 in its market
Stable Large shareholder and/or long term investor
Differentiated customer and product portfolio
Revenue growth >5% per year expected
Ford Motor Co.
Start price
Target price
Perf. (%)
€7.34
18.12.20
18.12.20
€12.00
18.12.21
18.12.21
35.66%
29.04.21
29.04.21
Fair valuation
Sustainability is important
Innovative
Growths slower than the competition
Box Inc. A
Start price
Target price
Perf. (%)
€15.47
18.12.20
18.12.20
€30.00
18.12.21
18.12.21
47.86%
19.12.21
19.12.21
Could be very worthwhile Investment >20% year
Fair valuation
Very capable Management
Plug Power Inc.
Start price
Target price
Perf. (%)
€24.98
18.12.20
18.12.20
€140.00
18.12.21
18.12.21
3.28%
19.12.21
19.12.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Medigene AG
Start price
Target price
Perf. (%)
€3.56
18.12.20
18.12.20
-
18.12.21
18.12.21
8.86%
27.02.21
27.02.21
Innovative
Dependend from some customers or products
Higher risks for its business
AstraZeneca plc
Start price
Target price
Perf. (%)
€83.36
18.12.20
18.12.20
€90.00
-3.42%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Higher risks for its business